Epithelial–mesenchymal transition (EMT) is a fundamental process driving cancer metastasis, transforming non-motile cells into a motile population that migrates to distant …
XN Meng, JF Ma, YH Liu, SQ Li, X Wang, J Zhu… - British Journal of …, 2024 - nature.com
Background Although DHFR gene amplification has long been known as a major mechanism for methotrexate (MTX) resistance in cancer, the early changes and detailed …
A current clinical challenge in cancer is multidrug resistance (MDR) mediated by ABC transporters. Breast cancer resistance protein (BCRP) or ABCG2 transporter is one of the …
M Katebi, S Rahgozar, F Kazemi, S Rahmani… - Cancer …, 2023 - Wiley Online Library
Plant‐based combination strategies have been widely considered in cancer therapy to attenuate chemotherapeutics side effects. The anti‐leukemic effect of the whole ginger …
B Samii, A Jafarian, M Rabbani… - Research in …, 2023 - journals.lww.com
Background and purpose: One strategy to overcome methotrexate (MTX) resistance in acute lymphoblastic leukemia is suppressing MDR1 expression. It has been proved Astragalus …
N Aberuyi, S Rahgozar - Clinical and Translational Oncology, 2022 - Springer
Purpose Appropriate sub-classification of leukemia according to the immunophenotypic characteristics of the malignant cells may improve therapeutic strategies. The aim of this …
This study aimed to figure out how microRNA (miR)-411-3p's impacts on methotrexate (MTX)'s cellular uptake and cytotoxicity in acute lymphoblastic leukaemia (ALL) CEM-C1 …